13 out of 15 miRNAs (87%) targeting CDH1 were upregulated in exosomes from HNSCC patients compared to HD (Supplementary Figure 2), which is consistent with the reduced expression of E-cadherin protein and mRNA observed with exosomes from before therapy in vitro. The gene discussed is CDH1; the disease is head and neck squamous cell carcinoma.